APOE and Alzheimer disease: In the AD (pathology) versus control analysis, there were 1917 (1049 upregulated) DEGs between non-carrier AD and non-carrier controls compared to 152 for APOE4 AD and APOE4 controls, with 50 in common (Transthyretin (TTR) common to top 20).